entertainment -WSS

entertainment

author：leisure time 2025-09-27 12:56:43 - browse：71756

The bacterium A. baylyi was engineered to detect a common cancer mutation. Courtesy of Josephine Wright

Dan Worthley, a gastroenterologist and cancer scientist at Colonoscopy Clinic in Brisbane, Australia, does thousands of colonoscopies a year, seeking and destroying precancerous polyps. It’s a practically surefire way to prevent colorectal cancer, but an unpleasant experience for patients. The future, Worthley hopes, will be much less onerous — and he’s developing a technology that, if it works one day, might make the experience more of a piece of cake.

Or, rather, a cup of yogurt — containing engineered bacteria that can detect and deliver a treatment for colorectal polyps or cancer. Worthley and colleagues at the University of California, San Diego, and the University of Adelaide published results in Science on Thursday that show they are one step closer to that far-off dream. In their paper, the researchers show a proof-of-concept engineered bacterium that can detect cancer DNA in the guts of mice and react to it by turning on certain cellular circuitry.

“I think it’s really cool. It introduces a new concept for how you can use cells as a sensor for something happening inside other cells,” said Mikhail Shapiro, a chemical and medical engineer at the California Institute of Technology who did not work on the study. “That can flip a switch inside those cells. In this case, it’s used for diagnostic output, but in principle it could be used for other things.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： J&J to buy cancer drug developer Ambrx Biopharma

leisure time

focus

WSS

'CMA Fest' 2023: How to watch, who is performing and more

The stock market has soared this year, but will it last? Experts weigh in

New weight loss drugs work. But how can they best be used?

Feng Zhang CRISPR delivery startup lays off quarter of staff

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

There’s a way to spot data fakery. All journals should be using it

focus

entertainment

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A single drug, study failures leave Anavex with nothing but cash

Hollywood unions extend contract negotiations for actors

JPM: CVS says Medicare Advantage patients are impacting profits

Walensky prepares to leave CDC — and Congress — behind

After a decade, new Gardasil ad campaign gets it (mostly) right

Tori Bowie and the unacceptable rates of Black maternal death

Sanders wants to replace patents with prizes for drug inventions

Supreme Court strikes down use of affirmative action

JPM: CVS says Medicare Advantage patients are impacting profits

hotspot

Videos point to link between seizures and unexplained toddler deaths

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Feng Zhang, Grail founder join forces on new gene editing startup

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

The stock market has soared this year, but will it last? Experts weigh in

leisure time

focus

focus

explore